Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
AstraZeneca
McKesson
Accenture
Fuji
Express Scripts
QuintilesIMS
Queensland Health
Teva

Generated: January 18, 2019

DrugPatentWatch Database Preview

NALTREXONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Naltrexone Hydrochloride, and when can generic versions of Naltrexone Hydrochloride launch?

Naltrexone Hydrochloride is a drug marketed by Accord Hlthcare, Apotex Inc, Barr, Elite Labs, Fosun Pharma, Specgx Llc, and Sun Pharma Global. and is included in seven NDAs.

The generic ingredient in NALTREXONE HYDROCHLORIDE is naltrexone hydrochloride. There are nineteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the naltrexone hydrochloride profile page.

Drug patent expirations by year for NALTREXONE HYDROCHLORIDE
Pharmacology for NALTREXONE HYDROCHLORIDE
Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists

US Patents and Regulatory Information for NALTREXONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 091205-001 Aug 17, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 076264-002 Mar 22, 2002 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Elite Labs NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 075274-001 May 26, 1999 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 076264-003 Mar 22, 2002 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 207905-001 Jul 21, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 074918-001 May 8, 1998 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Dow
Federal Trade Commission
US Army
Express Scripts
Argus Health
Johnson and Johnson
Chubb
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.